Key facts
- Notable investors include Dorm Room Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Sync Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Sync Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sync Bio
Manufacturer of modular lab-in-a-box systems designed to streamline laboratory tasks and improve efficiency. The company's platform provides customizable modules for functions such as liquid handling, imaging, incubation, and colony picking, with integration capabilities for third-party systems, enabling researchers and laboratories to reduce costs and space while automating complex biological workflows, thereby enhancing productivity and precision in laboratory environments.
- Sector
- Business Products and Services (B2B)
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Website
- sync.bio/
- Ownership
- Privately Held (backing)
Sync Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sync Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sync Bio in its N-PORT filings yet. We sweep new filings monthly.